Speaker illustration

Doctor Rui Adao

Complutense University of Madrid, Madrid (Spain)

Rui works as a research scientist at the Cardiovascular Research and Development Center - UnIC, at the Faculty of Medicine of the University of Porto (Portugal). His main scientific interests are pathomechanisms of pulmonary arterial hypertension and right ventricular failure. Rui has a strong expertise in animal models of pulmonary arterial hypertension (e.g., monocrotaline, hypoxia-Sugen5416) and in in vivo and in vitro evaluation of cardiac function. As an early career researcher, he has won numerous prestigious scholarships and awards such as Janssen Inovation Award (2018) or European Respiratory Society Short-Term Fellowship Grant (2017). His current research focuses on elucidating the role and therapeutic potential of novel small molecules (e.g., small peptides and microRNAs) in the setting of pulmonary arterial hypertension and associated heart failure. He is also a core member of the Scientists of Tomorrow Nucleus of the European Society of Cardiology.

Endothelial permeability, leakage and disease

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session type: Special Session

Thumbnail

Dietary interventions for optimised cardiovascular health

Event: ESC Congress 2021 - The Digital Experience

Topic: Basic Science

Session type: Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb